pharmajoblinks.com
Biotech JobLinks
http://www.pharmajoblinks.com/Biotech_JobLinks.php
Top Rx by Sales. Now that we are FREE, we're Under Construction. Some Links may not work! Biotech and BioPharmaceutical Company Direct JobLinks. Only companies traded on the US stock exchange. Direct JobLinks for that company. Aastrom Biosciences, Inc. Achillion Pharmaceuticals, Inc. Acorda Therapeutics, Inc. ADVENTRX Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. American Oriental Bioengineering, Inc. Amicus Therapeutics, Inc. Amylin Pharmaceuticals, Inc. Anika Therapeutics, Inc. ARCA biopharma, Inc.
biotechjoblinks.com
Members Biotech JobLinks
http://www.biotechjoblinks.com/Direct_Biotech_JobLinks.html
Brought to you by PharmaJobLinks.com LLC. Members Direct Biotech JobLinks. Biotech and BioPharmaceutical Company Direct JobLinks. Only companies traded on the US stock exchange. Direct JobLinks for that company. Aastrom Biosciences, Inc. Achillion Pharmaceuticals, Inc. Acorda Therapeutics, Inc. ADVENTRX Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. American Oriental Bioengineering, Inc. Amicus Therapeutics, Inc. Amylin Pharmaceuticals, Inc. Anadys Pharmaceuticals, Inc. Anika Therapeutics, Inc.
harbinus.blogspot.com
Harbinus - Thoughts on the world and markets
http://harbinus.blogspot.com/2005/12/american-oriental-bioengineering_04.html
Harbinus - Thoughts on the world and markets. Sunday, December 04, 2005. American Oriental Bioengineering (AOB:AMEX) (12-02-05 Closing Price $4.75 USD) Strong Buy - 12-month target price: $8.33. Part 2 of 2. Shuanghuanglian lyophilized poweder for injection (SLPI). AOB is well positioned from a market perspective to take advantage of the rising Chinese per-capita income, as well as an aging population. A wealthier consumer is often a more health conscious consumer, and AOB will benefit from an increa...
harbinus.blogspot.com
Harbinus - Thoughts on the world and markets: December 2005
http://harbinus.blogspot.com/2005_12_01_archive.html
Harbinus - Thoughts on the world and markets. Tuesday, December 13, 2005. Dec 13 - Update: China Energy Savings Technology (CESV). Rating on CESV, I maintain my long term price target and rating of strong buy. For the long term. To be honest I sold 40% of my CESV on this hunch, I hope to enter at a lower level, but will be back in the stock if they file on time. Taking profits may not be a bad idea depending on your risk profile. Posted by Harbinus at 3:53 PM. Monday, December 12, 2005. Cease Enuresis So...